Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Belimumab In Prevention of New-onset Lupus Nephritis In High Risk Patients

NCT05585671 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT05585671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05585671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Belimumab In Prevention of New-onset Lupus Nephritis In High Risk Patients
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2023
Completion date
June 1, 2026
Enrollment
48 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

whether belimumab could reduce 2-year risk of new-onset lupus nephritis